Patients with known LPL/WM or other IgM monoclonal gammopathy should be evaluated for possible amyloidosis in certain situations, and patients diagnosed with IgM-associated amyloidosis should complete an additional evaluation for lymphoma (Table 2). This evidence concerns the gene LPL and amyloidosis.